The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-27.9% to $65.00
Predicted High$95.00at 1 month
Predicted Low$65.00at 6 months
Max Drawdown (predicted)-27.9%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Sep 24, 2026 1:00 pm
Bear
CRWV trends lower to
$65.00
(-27.9% from $90.20)
by Mar 2027.
ride-then-fade
ThesisCRWV is a high-beta narrative name riding a fresh UBS Buy and a $4.2B financing win, but poor value/quality lenses (-77/-73) and a bear scenario of $25.82 create heavy long-term gravity. Expect near-term momentum extension then gradual fade as euphoria dissolves against forensic concerns.
Invalidated ifA break above $110 on sustained volume invalidates the fade; conversely a drop below $70 accelerates the decay faster than modeled.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $90.20 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Sep 24, 2026
—
$90.20at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Oct 8, 2026
$72.04–$108.36typical range · internal point $93.50
—
±20.1%
6/10
Momentum from UBS Buy and financing win extends
What actually happened:
closed $88.45
on Oct 7, 2026 = -1.9% vs the call
(predicted +3.7%)
· direction HIT
(called flat, was flat)
· off by 5.6 pp
· accuracy 8/10
· typical range ±20.1%:
inside the band
· S&P +1.3%
over the same window — lagged it
1 month
Oct 24, 2026
$63.89–$116.51typical range · internal point $95.00
—
±29.2%
5/10
Risk-on tape sustains high-beta narrative bid
Matured — awaiting scoring. This checkpoint's date has passed; the next scorer run
(score-outcomes.php) records what actually happened.
2 months
Nov 24, 2026
$88.00
—
-2.4%
4/10
Split analyst tone caps upside, drift begins
3 months
Dec 24, 2026
$82.00
—
-9.1%
4/10
Year-end derisking hits high-beta narrative names
4 months
Jan 24, 2027
$76.00
—
-15.7%
4/10
Value gravity from -77 lens starts asserting
5 months
Feb 24, 2027
$70.00
—
-22.4%
3/10
Forensic concerns weigh as euphoria fades
6 months
Mar 24, 2027
$65.00
—
-27.9%
3/10
Convergence toward attractive-below $55 zone
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.